Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

Rationale Though clozapine is recommended for treatment of tardive dyskinesia (TD)
relating to the use of antipsychotic medications, studies comprehensively investigating the …

The term, tardive dyskinesia (TD), originally was coined by Faurbye and colleagues 1 in
their description of delayed-onset, persistent, rhythmic, stereotyped movements after …

Patients with schizophrenia frequently suffer from motor abnormalities, but underlying
alterations in neuroarchitecture remain unclear. Here, we aimed to disentangle dyskinesia …

Tardive syndrome (TS) is an iatrogenic, often persistent movement disorder caused by drugs
that block dopamine receptors. It has a broad phenotype including movement …

Background: Tardive Dyskinesia (TD) is a neurological disorder characterized by involuntary
movements, often caused by dopamine receptor antagonists. Vesicular Monoamine …

Objective: This study compared the reporting frequency of tardive dyskinesia (TD) between
long-acting injectable antipsychotics (LAI-APs) and the equivalent oral antipsychotics (O …

Objective Previous studies have shown that transcranial direct current stimulation (tDCS) led
to an improvement of cognitive function in patients with schizophrenia, but rare study has …

Abnormal movements are intrinsic to some forms of endogenous psychoses. Spontaneous
dyskinesias are observed in drug-naïve first-episode patients and at-risk subjects. However …

Tardive dyskinesia (TD) is a phenomenon observed following the predominantly long-term
use of dopamine receptor blockers (antipsychotics) widely used in psychiatry. TD is a group …